Overview

A Study in Evaluating Bioequivalence of Test and Reference Vadadustat 450 MG and 150 MG Tablets and to Determine Food Effect on the 450 MG Tablet

Status:
Completed
Trial end date:
2018-10-16
Target enrollment:
Participant gender:
Summary
This is a healthy volunteers study to assess the bioequivalence of vadadustat 450 mg tablets (Test A) compared to three 150mg tablets (Reference B). The study will also assess the effect of food on the bioavailability of vadadustat 450 mg tablet.
Phase:
Phase 1
Details
Lead Sponsor:
Akebia Therapeutics